SDSeniz Demiryürek

Seniz Demiryürek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seniz Demiryürek has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Adenosine in Testicular and Ovarian Ischemia/reperfusion Injury

    by Nazlıcan İğci, Azad Mammadov, Şeniz Demiryürek, Abdullah Tuncay Demiryürek

    Objective: The purpose of this review is to comprehensively evaluate the potential role of adenosine in testicular and ovarian ischemia/reperfusion (I/R) injury. This review provides an overview of the current role of adenosine receptors in I/R injury due to testicular and ovarian torsion/detorsion (T/D). This review article presents an updated summary of the effects of adenosine receptor agonists and antagonists on testicular and ovarian tissues. Methods: A comprehensive literature search was performed in PubMed, Web of Science, Cochrane Library, and ClinicalTrials.gov. The final search was conducted on June 15, 2026, covering the period from January 1, 2020. The search primarily focused on studies published within the last five years, but earlier significant studies were included where necessary to provide historical context or general information. Only original articles published in the English or Turkish language in peer-reviewed journals were included in the review. Narrative and systematic reviews, conference proceedings, expert opinions, and case reports were excluded from the review. Results: Modulation of adenosine receptors may play an important role in the pathophysiology of testicular and ovarian ischemia. Among the receptor subtypes, A1 and A2A receptor agonists generally demonstrated protective effects in experimental models, whereas evidence regarding A2B and A3 receptors remains limited and, in some cases, inconsistent. The magnitude of these effects appears to depend on receptor subtype, pharmacological agent, dose, timing of administration, and experimental model. However, current evidence is derived predominantly from preclinical studies. Conclusion: The use of adenosine receptor agonists may provide protective effects on testicular and ovarian damage induced by T/D or I/R. These agents may hold promise in the treatment of testicular and ovarian ischemia. However, the current evidence is predominantly preclinical, and more well-designed preclinical and clinical trials are needed before it can be implemented in clinical practice.

  • Open Access

    Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats

    by Azad Mammadov, Abdullah Tuncay Demi̇rYürek, Ahmet Saracaloğlu, Cahi̇t Demi̇rKiran, İsMai̇l Tuncer Deği̇m, Ömer Eronat, Şeni̇z Demi̇rYürek

    Background/aim: To determine the effects of an A2A receptor agonist regadenoson, an A2A receptor antagonist istradefylline, and istradefylline nanosuspension on ovarian ischemia/reperfusion (I/R) injury in rats. Materials and methods: A total of 80 female rats were divided into 10 groups: sham, ovarian I/R, blank nanosuspension + ovarian I/R, regadenoson (3 μg/kg) + ovarian I/R, regadenoson (30 μg/kg) + ovarian I/R, istradefylline (0.3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + ovarian I/R, istradefylline-loaded nanosuspension (3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R, and istradefylline-loaded nanosuspension (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R. ELISA, chemiluminescence, and spectrophotometric analyses were performed on blood and ovarian tissue samples. Histopathological changes were analyzed using hematoxylin and eosin staining, and a scoring system was applied to assess ovarian tissue damage. Results: Serum malondialdehyde levels were augmented in the I/R and blank nanosuspension + I/R groups. Although tissue superoxide dismutase levels were decreased with I/R, these levels were increased with regadenoson (3 μg/kg), istradefylline (0.3–3 mg/kg), and istradefylline nanosuspension (3 mg/kg). While there was augmentation in the serum and tissue 3-nitrotyrosine levels in the I/R group, a marked decrease was identified with regadenoson (30 μg/kg, p < 0.05). Native thiol levels were decreased in the I/R group, and this decrease was prevented by regadenoson. Serum disulfide levels were increased in the I/R group, and this increase was suppressed by regadenoson. Conclusion: These data showed that adenosine A2A receptors may contribute to the ovarian I/R injury and regadenoson can produce protective effects.


  • Open Access

    Evaluating the impact of radiotherapy on nitrosative stress and thiol/disulfide dynamics in patients with lung cancer

    by Ayse Gulbin Kavak, Seniz Demiryürek, Ihsan Karslioglu, Ahmet Saracaloglu, Abdullah Tuncay Demiryürek

    This study aimed to prospectively examine the systemic effects of curative radiotherapy on dynamic thiol/disulfide homeostasis and nitrosative stress markers in patients diagnosed with lung cancer. Forty-one patients diagnosed with lung cancer and 41 healthy controls were enrolled in the study. Serum nitric oxide, 3-nitrotyrosine, total thiol, native thiol, and disulfide levels were measured from blood specimens taken from patients before radiotherapy and 24 h after radiotherapy. Nitric oxide levels were analyzed by chemiluminescence technique, 3-nitrotyrosine levels by ELISA, and thiol/disulfide homeostasis parameters by spectrophotometric methods. Serum nitric oxide (NO) and 3-nitrotyrosine levels of patients were significantly elevated in both pre-radiotherapy and post-radiotherapy periods compared to the healthy control group (p < 0.001). NO levels tended to increase after RT, but this difference did not reach statistical significance. Total thiol and native thiol levels in the pre-radiotherapy and post-radiotherapy periods were decreased when compared to the controls (p < 0.001). Post-radiotherapy disulfide levels were markedly higher than the pre-radiotherapy (p < 0.05) and the controls (p < 0.05). Similarly, while disulfide/total thiol and disulfide/native thiol ratios were increased in the post-radiotherapy period, a marked decline was observed in the native thiol/total thiol ratio in the post-radiotherapy period (p < 0.05). Since chemotherapy is also known to affect redox homeostasis, the combined treatment (chemoradiotherapy) is likely responsible for the observed biochemical changes seen in our study. Our suggest that radiotherapy further exacerbates the already imbalanced redox homeostasis in lung cancer patients by enhancing NO production and promoting thiol oxidation. Concurrent chemoradiotherapy appears to exacerbate the imbalance in redox homeostasis in lung cancer patients.


  • Investigation of histatin-1, histatin-3, and histatin-5 peptide levels in corneal epithelial cells obtained from patients with keratoconus

    by Cahit Demirkiran, Abdullah Tuncay Demiryürek, Alper Mete, Ahmet Saracaloglu, Mustafa Şahin, Şeniz Demiryürek

    Purpose: The aim of this research was to investigate the contribution of histatin peptides in the pathophysiology of keratoconus. Methods: This prospective study investigated the presence of histatin peptides in corneal epithelial samples taken from 66 adult patients with keratoconus (stage 1, n = 22; stage 2, n = 21; and stage 3, n = 23) and 20 postmortem controls. The histatin-1, −3, and −5 levels were measured using the ELISA method. Results: Histatin-3 significantly increased in stage 1 (control, 274.05 ± 15.72 ng/mg total protein, vs. patients, 528.17 ± 47.45 ng/mg total protein, p < 0.001) and stage 2 (374.33 ± 15.05 ng/mg total protein, p < 0.05), but no changes for histatin-1 and −5 levels were observed. Histopathological analysis showed that corneal epithelial cell thickness increased in keratoconus, and this increase augmented proportionally with the stages. The histopathological scores were significantly elevated in stages 2 and 3. Interestingly, positive correlations were observed between histatin-1 and histatin-3 levels in all stages. Conclusion: These preliminary data suggest that histatin-3 may be involved in the early stages of keratoconus. These findings are preliminary and should be confirmed in larger, prospective cohorts.

  • Nitrosative Stress, Mitochondrial Peptides, and Ferroptosis Markers in Corneal Epithelial Cells from Keratoconus Patients

    by Cahit Demirkiran, Alper Mete, Abdullah Tuncay Demiryürek, Ahmet Saracaloglu, Şeniz Demiryürek

    To investigate the possible contribution of nitrosative stress, mitochondrial peptide levels (humanin and mitochondrial open-reading frame of the 12S rRNA-c), and ferroptosis parameters in corneal epithelial cells obtained from patients with keratoconus. This prospective study was conducted on corneal epithelial cell samples taken from 75 adult patients with keratoconus and 25 age-matched postmortem controls. The Amsler-Krumeich classification was used for staging the keratoconus. All parameters, except nitric oxide, were measured by ELISA, and nitric oxide levels were determined by the chemiluminescence method. Humanin levels in keratoconus corneal epithelial cells were increased in stage 3 (p < .05), while mitochondrial open-reading frame of the 12S rRNA-c (p < .01) levels were diminished in all stages. Significant increases in nitric oxide (p < .001) and 3-nitrotyrosine (p < .05) levels were detected in the keratoconus group, indicating the involvement of nitrosative stress. In stage 3, glutathione peroxidase 4 levels were shown to be decreased (p < .01), while long-chain fatty acid CoA ligase 4 (p < .05) and malondialdehyde (p < .05) levels were increased. This is the first study to show that humanin and mitochondrial open-reading frame of the 12S rRNA-c can participate in the pathophysiology of keratoconus. In addition to the mitochondrial peptides, our data suggest that increased nitrosative stress and ferroptosis may contribute to the pathophysiology of keratoconus.


  • Open Access

    Evaluation of TNF (rs1800629), TLR2 (rs111200466), and TLR4 (rs4986790) gene polymorphisms in adult patients with acute appendicitis

    by Yusuf Ertugrul Aslan, Elif Funda Şener, Nahide Ekici Günay, Emre Tuğhan, Tuğba Coşkun Aslan, Şeniz Demiryürek

    Objectives: Acute appendicitis (AA) is the primary cause of urgent surgery. The goal of this case-control study was to establish the possible associations of tumor necrosis factor (TNF), toll-like receptor-2 (TLR2), and toll-like receptor-4 (TLR4) gene polymorphisms in cases of AA in a Turkish population. Methods: This prospective research was performed on 160 AA cases admitted into the Erciyes University Emergency Medicine Department. A total of 197 healthy volunteers were also included as a control group. TNF –308 G>A (rs1800629), TLR2 −196 to −174 del/ins (rs111200466), and TLR4 (Asp299Gly, 896A>G, rs4986790) polymorphisms were analyzed using real-time polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLR) methods. Results: The TNF rs1800629 polymorphism had significant increases in the patient group’s A allele frequencies and AA genotype (p0.05), no significant correlations were found in the genotype frequencies. Conclusions: This research demonstrated that TNF −308G>A, but not the TLR2 (−196 to −174 del/ins) or TLR4 Asp299Gly variant, is a contributing factor to the susceptibility of AA development in the Turkish population.

  • Recent Progress and Perspectives in Sodium-Glucose Co-transporter 1/2 Inhibitors

    by Cahit Demirkiran, Seniz Demiryurek, Abdullah Tuncay Demiryurek

    Sodium‐Glucose Co‐transporter‐1/2 (SGLT1/2) inhibitors (also called glifozins) are a class of glucose‐decreasing drugs in adults with Type 2 Diabetes (T2D). SGLT2 inhibitors diminish sodium and glucose reabsorption in the renal proximal convoluted tubule. Recent clinical trials have revealed that SGLT2 inhibitors might be beneficial for treating diseases other than diabetes, including chronic renal disease and Heart Failure (HF). Currently, SGLT2 inhibitors are recommended not only for the glycemic management of T2D but also for cardiovascular protection. SGLT2 inhibitors have become one of the foundational drugs for HF with reduced Ejection Fraction (HFrEF) treatment and the first medications with proven prognostic benefit in HF with preserved Ejection Fraction (HFpEF). At present, 11 SGLT1/2 inhibitors have been approved for clinical use in different countries. Beyond their anti-hyperglycemic effect, these inhibitors have shown clear cardio- and nephroprotective properties. A growing body of research studies suggests that SGLT1/2 inhibitors may provide potential clinical benefits in metabolic as well as oncological, hematological, and neurological disorders.


  • Impact of Radiation Therapy on Serum Humanin and MOTS-c Levels in Patients with Lung or Breast Cancer

    by Ayse Gülbin Kavak, Ihsan Karslioglu, Ahmet Saracaloglu, Seniz Demiryürek, Abdullah Tuncay Demiryürek

    Background:: Lung and breast cancer are the most frequent causes of death from cancer globally. The objectives of this research were to evaluate the serum mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) and humanin levels in lung or breast cancer patients, and investigate the impacts of radiation therapy on the circulating levels of these peptides. Methods:: 35 lung cancer patients, 34 breast cancer patients, and healthy volunteers as a control group were recruited in this prospective observatory research. Lung cancer patients with stage IIIA/IIIB were treated with paclitaxel-based chemotherapy plus radiotherapy (2 Gy per day, 30 times, 60 Gy total dose). Breast cancer stage IIA/IIB patients were treated with postoperative locoregional radiation therapy (2 Gy per day, 25 times, 50 Gy total dose). The ELISA method was used to detect serum humanin and MOTS-c levels during, before, and after radiotherapy. Results:: We observed marked elevations in circulating MOTS-c, but not humanin levels in patients with lung cancer (P < 0.001). Radiation therapy led to a marked augmentation in MOTS-c levels in these patients (P < 0.001). On the other hand, there was a marked decline in humanin, but not MOTS-c, levels in breast cancer patients (P < 0.001). Conclusion:: Our research has shown, for the first time, that increased MOTS-c and decreased humanin levels play a role in lung cancer and breast cancer, respectively. Additionally, radiotherapy modifies MOTS-c levels in patients with lung, but not breast cancer.


  • Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure

    by Hatice Asil, Abdullah Tuncay Demiryürek, Irfan Veysel Düzen, Osman Büyükcelebi, Ahmet Saracaloglu, Cahit Demirkiran, Şeniz Demiryürek